Petrichor Healthcare Capital Management
Overview
Petrichor Healthcare Capital Management is a private equity firm specializing in healthcare investments, focusing on biopharmaceuticals, medical technology, and diagnostics. The firm partners with world-class healthcare managers and businesses to provide customized investment structures and support. Since its inception, Petrichor has completed over 80 investments representing more than $5 billion in invested capital and has held over 30 board seats across the industry. The team comprises professionals from highly-regarded financial institutions, including OrbiMed Advisors and Fortress Investment Group, bringing a deep in-house understanding of healthcare products and services, including scientific, technical, and commercial expertise. This expertise, combined with experience investing across sectors, geographies, and capital structures, provides a strong competitive advantage in building successful companies. Petrichor's portfolio includes notable partners such as ClearPoint Neuro, CorneaGen, Cryoport, LumiraDx, and Persivia. The firm's strategic approach spans company formation through late-stage and commercial growth opportunities, maintaining a long-term and strategic focus to drive scientific and medical innovation. Petrichor's deep industry expertise creates portfolio relationships beyond capital, helping private or public companies around the world achieve their growth potential.
Investment Focus
- Focus on biopharmaceuticals, medical technology, and diagnostics
- Interest in early-stage to pre-IPO companies
- Preference for companies with strong growth potential
Portfolio Companies
Reach Petrichor Healthcare Capital Management directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Petrichor Healthcare Capital Management
What sectors does Petrichor Healthcare Capital Management invest in?
Petrichor Healthcare Capital Management invests in Diagnostics, Medical Technology and Biopharmaceuticals, and is based in New York, United States. Petrichor Healthcare Capital Management is listed as a private equity in the ConnectSafely investor database.
What stage does Petrichor Healthcare Capital Management invest at?
Petrichor Healthcare Capital Management backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 5M - 50M.
Which regions does Petrichor Healthcare Capital Management invest in?
Petrichor Healthcare Capital Management invests across United States.
Who are the partners at Petrichor Healthcare Capital Management?
Team members listed for Petrichor Healthcare Capital Management include Tadd Wessel (Founder, Managing Partner) and Hayden Fownes (Vice President).
What companies has Petrichor Healthcare Capital Management invested in?
Petrichor Healthcare Capital Management's portfolio includes ClearPoint Neuro, LumiraDx, Cryoport, CorneaGen and Persivia.
How do I contact Petrichor Healthcare Capital Management?
Petrichor Healthcare Capital Management's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
